<DOC>
	<DOCNO>NCT02974751</DOCNO>
	<brief_summary>The purpose study evaluate efficacy AQUABEAM System treatment Lower Urinary Tract Symptoms ( LUTS ) result Benign Prostatic Hyperplasia ( BPH ) .</brief_summary>
	<brief_title>Global Post-Market Registry Using Waterjet Ablation Therapy Endoscopic Resection Prostate Tissue</brief_title>
	<detailed_description />
	<criteria>Male Subject diagnosis lower urinary tract symptom due benign prostatic enlargement cause bladder outlet obstruction urinary retention Prostate size ≥ 20 mL ≤ 150 mL measure TRUS Patient mentally capable willing sign studyspecific inform consent form Patients unable stop anticoagulant , antiplatelet agent , nonsteroidal antiinflammatory agent ( NSAIDs , include aspirin great equal 100mg ) prior treatment per standard care History gross haematuria Participants use systemic immunesuppressants include corticosteroid ( except inhalant ) , know coagulopathy , platelet disorder ( except aspirin 100mg/d ) Contraindication general spinal anesthesia Any severe illness would prevent complete study participation confound study result Subject unwilling accept transfusion one require</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>